Close Menu

NEW YORK – Natera on Tuesday sued molecular diagnostics and consulting firm Genosity for alleged patent infringement relating to technology from ArcherDx.

In its complaint, filed with the US District Court for the District of Delaware, Natera claimed that several of Genosity's products infringe its US Patent No. 10,732,220, titled "Methods for Simultaneous Amplification of Target Loci."

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

NPR reports the US Food and Drug Administration has approved a treatment for a genetic disorder that causes rapid aging.

Late-stage testing indicates the AstraZeneca and Oxford University SARS-CoV-2 vaccine can have up to 90 percent efficacy, the Associated Press reports.

ScienceInsider reports Nature Communications is reviewing a paper on mentorship following social media criticism arguing it is sexist.

In PLOS this week: method to account for sequencing errors in phylogenies, study of influenza A in Switzerland, and more.